Adhesive World: May 2012

Covalon Technologies, an advanced medical technologies company, announced United States Food and Drug Administration ("FDA") approval of IV Clear™, a breakthrough antimicrobial silicone adhesive film dressing designed for securing vascular intravenous access devices. Covalon's IV Clear antimicrobial film dressings have a number of unique and highly desirable characteristics:

IV Clear is the only vascular access securement dressing approved by the FDA that combines the comfort of skin-friendly silicone adhesive technology with the advanced antimicrobial protection of two gold-standard antimicrobial agents - chlorhexidine and silver.

IV Clear has uniquely bonded the two antimicrobials into the actual adhesive of the soft and non-sensitizing silicone that allows the clear film dressing to comfortably secure vascular access devices to the skin while providing antimicrobial protection for up to 7 days.

"IV Clear is truly a new innovation in the fight against Catheter Related Blood Stream Infections (CRBSI), for which the Center for Disease Control (CDC) calls one of the most deadly and costly threats to patient safety," said Brian Pedlar, Covalon's Chief Executive Officer. With over 350 million IV catheter stabilization devices used in the United States alone and the adoption of antimicrobial securement devices experiencing double-digit growth, we fully expect IV Clear to be a strong competitor in the market." Covalon Technologies produces SilverCoatTM Antimicrobial Silicone Foley Catheter as well as IV Clear™ antimicrobial silicone adhesive film dressing.

Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies that help save lives around the world. Covalon was founded by a group of entrepreneurial PhD's from the University of Toronto who recognized an opportunity to serve the global community through the development of patented medical technology in the areas of infection control, advanced wound care and medical coatings. Covalon became a publically traded company in 2004 and successfully built partnerships with both small and large companies using a strategic business foundation based on advanced scientific and engineering know-how. Starting in 2010, Covalon added a management team with significant success in growing medical companies to help propel Covalon forward into a mature and well respected medical industry partner.


 Agra Net: May 2012

EU ministers have formally approved new rules covering the registration of biocides. The Council adopted a regulation concerning the placing on the market and use of biocidal products (PE-CONS 3/12), which include insecticides, disinfectants and repellents. The regulation shall apply from 1 September 2013 with a transitional period for certain provisions.

The purpose of this regulation is to simplify the authorisation procedures in the internal market through the harmonisation of legislation on biocidal products, while ensuring a high level of protection for both human and animal health and the environment .

On the basis of the precautionary principle, the regulation lays down rules in particular for:

– the establishment at Union level of a list of active substances which may be used in biocidal products;

– the granting of an authorisation to biocidal products;

– the mutual recognition of authorisations within the Union, so as to reduce the administrative burden on producers; 

– the making available on the market and the use of biocidal products within one or more  member states or the Union;

– the placing on the market of treated articles (articles incorporating pest control chemicals: they may not be treated with unauthorised chemicals anymore and must be labelled under the conditions specified in the Regulation. These obligations apply to all articles treated with biocidal products on the EU market, including imported ones).

Furthermore, the regulation introduces the possibility of granting an Union authorisation for biocidal products, in addition to the current system of national product authorisation. A first series of product-types may be authorised at Union level as from 2013. From 2020 onwards, most biocidal products will qualify for this procedure. 


 Press Release: May 2012

Since April 2012, Aegis is now part of Microban International. Microban International is the global leader in built-in antimicrobial product protection, engineering durable antimicrobial solutions for consumer, industrial and medical products around the world.

As part of the integration, Microban is incorporating Aegis Microbe Shield technology into our portfolio of antimicrobial technologies. Microban utilizes a technology agnostic approach to product development by leveraging a broad range of organic, inorganic and organometallic technologies to provide you with the optimal solution for your unique product application.

The Microban brand serves as a trustmark for safe, durable, and effective antimicrobial technology. Today over 250 companies are leveraging the Microban brand and technologies as an important point of differentiation to help grow their businesses.

W.M. Barr & Co. Inc. has acquired Microban International Ltd., a developer of antimicrobial cleaners for kitchen and bath products, appliances and food service products. Financial aspects of the deal were not immediately disclosed; the deal was partially financed by BBH Capital Partners IV.

The acquisition is the largest in W.M. Barr's history, according to a company statement. In the last few years, W.M. Barr has acquired seven other companies, with the latest being Aegis, an antimicrobial company similar to Microban, in 2010. WM Barr brands include well known products such as Goof Off®, Mold Armor®, Klean-Strip®, Damp-Rid® and Aegis®, a leader in quaternary ammonium based antimicrobial compounds for textiles and footwear. The 100% employee-owned company was founded in 1946 and is headquartered in Memphis, Tennessee

David Meyers, current CEO of Microban, will remain in place and the company will maintain its Huntersville, N.C., headquarters, operating as an independent subsidiary. Microban has facilities throughout North America, Europe and Asia.

Memphis-based W.M. Barr employs 356 people, including 321 locally, and provides cleaning products to consumer and industrial customers. According to Memphis Business Journal research, W.M. Barr had revenue of $214 million in 2010.


 Press Release: May 2012

SANITIZED AG launches a new generation of silver-based antimicrobial protective additives that deliver effective protection faster than ever before and at concentration loadings lower than previously possible. The new Sanitized® Silver products also offer best-yet transparency for applications requiring fast and broad protection against microbes.

The new Sanitized® antimicrobial protection package, from Switzerland's world-leading producer of antimicrobial hygiene function and material protection for textiles and plastics, completes the Sanitized® silver-based product range of natural and safe active ingredients. These ingredients continue to perform after regular and lifetime cleaning measures and inhibit germ growth for optimum hygiene and to prevent unpleasant odors around the clock even when in contact with humidity.

The new Sanitized® silver-based antimicrobials are unique in the speed at which they become active in combination with low application concentrations; contributing factors to the additives' excellent price/performance ratio. The patented technology of silver encapsulated in a glass ceramic material, in combination with a low particle size of the product, delivers one of the highest levels of transparency which, when used in coatings, means quality and aesthetics of the end-use application are not compromised. This technology is effective against a large number of bacteria and remains stable at temperatures up to 500⁰C—far beyond any organic active compounds.

The new products are compatible with a wide range of polymers, in particular Polyolefins, Polystyrene and Polyurethanes, and work also in powder and liquid coatings. Due to their process stability they fit perfectly as a masterbatch (MB) for molding processes. This level of flexibility and robustness means that applications such as coatings on furniture and vinyl flooring as well as fibers for carpeting, bedding, mattress covers and pillow filling work easily well alongside cleaning aids such as brooms, mops and cloths.

For packaging films where the highest levels of hygiene and protection are paramount, through to non-woven materials that offer security and comfort in automotive seating and interior coverings, Sanitized® offers the well-known and accepted protection properties with the added values of speed and economic sustainability. In the world of personal-care, items such as tooth brushes made from hard injection molded plastics can receive the same level of protection as sanitary ware, ranging from basins, toilet seats to bath tubs and shower cubicles.

The use of silver as an effective antibacterial agent has been known to man since Roman times. In the last 50 years, SANITIZED AG has introduced a number of silver-based antimicrobial products that have contributed to our health and well being and can be found in a wide range of applications from fibers to coatings as well as a wide range of molded polymers.

"Silver products have an excellent reputation for a wide range of performance characteristics. The new Sanitized® Silver products provide a package of benefits that ensure fast and durable antimicrobial protection while remaining economically sustainable without compromising aesthetics and performance," comments Maria Toscan, Product Manager Polymers at SANITIZED AG.


 World Poultry: May 2012

Dow Microbial Control has launched a comprehensive educational campaign called "GENUINE GLUTARALDEHYDE" intended to help customers distinguish glutaraldehyde from counterfeit product options while simultaneously promoting the numerous benefits of glutaraldehyde.

Successfully introduced more than 60 years ago, glutaraldehyde is one of Dow Microbial Control's flagship molecules. This versatile microbiocide offers a host of advantages in applications ranging from high-level disinfection of medical equipment employed in healthcare settings to controlling microbes found in industrial operations such as oilfields and cooling towers to disinfecting poultry and swine facilities.

"During the past few years, formulators have increasingly made and sold products that are supposedly glutaraldehyde-based, but actually contain other ingredients, including formaldehyde and glyoxal," said Mark Henning, global general manager for Dow Microbial Control. "The bottom line is that if your product does not contain genuine glutaraldehyde, you may very likely have a product with a blend of formaldehyde and/or glyoxal and possibly some small amount of glutaraldehyde. Customers could be overpaying by 50 to 200 percent, based on current average market prices for these blended materials. Moreover, there are often environmental, health and safety issues to consider with these blended products, and the personal protective equipment requirements may differ – especially for free formaldehyde, which is a known carcinogen."

In conjunction with its GENUINE GLUTARALDEHYDE program, Dow Microbial Control has developed a variety of beneficial materials. These include a GENUINE GLUTARALDEHYDE Cost Calculator to determine how much customers should be paying for their blended products, as well as detailed technical information and fact sheets, a compendium of glutaraldehyde milestones and other helpful information.

To better educate potential customers, educators and scientists about glutaraldehyde's proven benefits, research and development initiatives, and updates, Dow Microbial Control is utilizing Heather McGinley, Ph.D., as the focal point of a widespread educational campaign. An associate scientist with the company, McGinley has conducted extensive research about glutaraldehyde and presented a variety of technical papers at prominent industry conferences and events.

"Glutaraldehyde was first produced commercially in 1951 and offers a host of important microbial control benefits that have been confirmed through six decades of usage," said Rick Strittmatter, global director of research and development for Dow Microbial Control. "This versatile product provides broad efficacy, is biodegradable and formaldehyde free, and is also non-carcinogenic, non-persistent and non-bio-accumulative, which distinguishes it from many other biocides."

Although glutaraldehyde is often confused with formaldehyde and shares the chemical family name "aldehyde," their chemical and toxicological properties differ significantly. In addition, genuine glutaraldehyde neither contains nor degrades into formaldehyde.

"Glutaraldehyde is a terrific option for many applications, and we remain committed to developing innovative and sustainable solutions that help customers manage their microbial control challenges as effectively as possible," said Suzanne Carroll, Dow Microbial Control's global commercial director. "We encourage customers to ask for genuine glutaraldehyde-based products from The Dow Chemical Company or BASF – the world's only two manufacturers of glutaraldehyde – so they know they are getting what they desire rather than blends incorporating little or no glutaraldehyde that may falsely claim to be glutaraldehyde-based. Dow Microbial Control is placing a special "Formaldehyde Free" seal on many of our glutaraldehyde products to distinguish them from potential imitators and let customers know they are receiving genuine glutaraldehyde and not overpaying for an inferior product."

Dow Microbial Control has also created a special website devoted to glutaraldehyde, which is accessible at www.Glutaraldehyde.com. It features useful glutaraldehyde-related information, including links to technical documents and resources. Visitors to the site who successfully answer several questions about glutaraldehyde will be entered in a random drawing for a chance to win an Apple® iPad®.